Evaluation of HER2/neu and SPINK1 as an adjunct to the prognosis of urothelial dysplasia and urothelial carcinoma of the urinary bladder

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression

Assessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics

Evaluation of pyruvate kinase M2 (PKM2) and epidermal growth factor receptor (EGFR) expression and their clinicopathologic significance in bladder urothelial carcinoma

TROP-2: a unique immunohistochemical marker for diagnosis of papillary thyroid carcinoma

Role of YAP1 and tumor-associated macrophages in urothelial carcinoma of urinary bladder: Histopathological and immunohistochemical studies

Role of expression of p53 and Ki67 in the progression of Wilms tumor: Correlation with patients’ survival

Impact of SOX2 and CD44 as Cancer Stem Cell Markers in Urinary Bladder Carcinoma

Significance of D2-40 and CXCL5 Expression in Urinary Bladder Transitional Cell Carcinoma: An Immunohistochemical Study

Biochemical study of E-Cadherin and SATB1 in Urothelial Bladder Carcinoma of Egyptian Patients